IVVD
Invivyd Inc
Chart
Technical data
$1.03
-7.21%
$0.08
25
$1.19 (-13.7%)
$1.37 (-24.9%)
$1.70 (-39.3%)
$1.81 (-43.1%)
$3.07 (-66.4%)
$0.48 (+113.3%)
3.13M
0.73
2026-06-05
739771
Declining
502
-36.57%
-12.00%
2.71%
0.76
17
100%
300
1213
2026-06-09
$1.11
17
2026-06-05
Upcoming confluences
| Date | Price | Score | Price levels | Time levels |
|---|---|---|---|---|
| 2026-06-09 | $1.11 | 3 | 13 | 8 |
Fundamental data
Invivyd Inc
Healthcare
Biotechnology
$329.96M
$3.45M
234.09M
—
13.27%
10.09
-49.78%
21.07%
—
25
—
Fundamental analysis
No analysis yet. This will pull the latest 10-K, 10-Q, and DEF 14A from SEC EDGAR, ingest the company's XBRL financial facts, compute Beneish / Altman / Piotroski / Sloan / Penman–Nissim, run Greenwald EPV + Mauboussin reverse-DCF, and synthesise a Columbia-style moat, earnings quality, and capital allocation review. Cached for 90 days.
News (1)
| Published (UTC) | Session | Sentiment | Category | Move % | Headline |
|---|---|---|---|---|---|
| 2026-06-01 07:01 | AfterHours |
Bullish |
Phase3Positive |
7.02% | Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID |
SEC Filings (0)
No SEC filings cached for CIK 1832038 yet — run a fundamental analysis to import the last 3 years.
Beneficial Ownership 5%+ (0)
No SC 13D / 13G filings parsed for this symbol in the last 2 years.
Institutional Holders (0)
CUSIP not yet known for IVVD. Three population pathways: (1) the next fundamental analysis run extracts it from any SC 13D/G cover page filed against IVVD (cover pages print the subject-company CUSIP near the top); (2) the daily Form13FIngestionJob auto-links from a 13F-HR holding whose IssuerName uniquely matches IVVD's CompanyName; (3) manual SQL update on the Tickers row. Once linked, institutional holders appear below.
Current setups (0)
No open or triggered setups for IVVD right now.